H1B Report
Side-by-side comparison

INFOSYS LIMITED vs Novartis Institutes for BioMedical Research, Inc.

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
INFOSYS LIMITED
TXRank #1FEIN 58-1760235

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricINFOSYS LIMITEDNovartis Institutes for BioMedical Research, Inc.
Total filings205,263964
Certified %99.55%96.37%
Denied %0.21%0.93%
Withdrawn %0.20%1.76%
Cert-withdrawn %0.05%0.93%
Rank#1
Active yearsFY2010–FY2026FY2010–FY2026
Worksite stateTXNJ

Outcomes — INFOSYS LIMITED

DOL case-status mix.

Outcome breakdown: Certified 99.5%, Cert-withdrawn 0.0%, Withdrawn 0.2%, Denied 0.2%
Outcome breakdown
OutcomeShare
Certified99.5%
Cert-withdrawn0.0%
Withdrawn0.2%
Denied0.2%
Certified99.5%
Cert-withdrawn0.0%
Withdrawn0.2%
Denied0.2%

Outcomes — Novartis Institutes for BioMedical Research, Inc.

DOL case-status mix.

Outcome breakdown: Certified 96.4%, Cert-withdrawn 0.9%, Withdrawn 1.8%, Denied 0.9%
Outcome breakdown
OutcomeShare
Certified96.4%
Cert-withdrawn0.9%
Withdrawn1.8%
Denied0.9%
Certified96.4%
Cert-withdrawn0.9%
Withdrawn1.8%
Denied0.9%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

INFOSYS LIMITED
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20102,164
FY20111,681
FY201214,701
FY201332,232
FY201423,749
FY201533,214
FY201625,335
FY201720,571
FY201811,569
FY201921,420
FY202016
FY202129
FY202222
FY20232,269
FY20245,943
FY20255,790
FY20264,558
Novartis Institutes for BioMedical Research, Inc.
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY201065
FY201154
FY201264
FY201358
FY201480
FY201569
FY201676
FY201782
FY201862
FY201970
FY20204
FY20219
FY20226
FY202313
FY2024106
FY202592
FY202654

Top 5 occupations — INFOSYS LIMITED

Top 5 occupations — Novartis Institutes for BioMedical Research, Inc.

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.